A CT Gout scan using Dual‑Energy CT (DECT) is a specialised imaging test that identifies uric acid crystal deposits in joints and soft tissues. It helps diagnose gout when symptoms are unclear or when joint aspiration is difficult. At Advicon Imaging, DECT gout scans are bulk‑billed for Medicare‑eligible patients.

On this page
A Dual‑Energy CT (DECT) scan for gout is an advanced imaging technique designed to detect monosodium urate (MSU) crystals—the substance responsible for gout. Unlike conventional CT scans, DECT uses two different X‑ray energy levels to distinguish uric acid crystals from calcium and other tissues. This allows doctors to visualise crystal deposits clearly, often shown as colour‑coded areas on the images.
DECT is particularly helpful when joint aspiration is not possible, when tests are inconclusive, or when gout presents in atypical ways. It is commonly used for patients with chronic gout, recurrent pain or swelling, or suspected tophaceous gout. DECT can also assist in treatment planning by identifying how extensive the crystal burden is and by monitoring changes over time.
Although DECT is highly accurate, it may have reduced sensitivity during a first acute flare or in patients with significant osteoarthritis, where calcium deposits may mimic uric acid. For this reason, doctors interpret DECT findings alongside clinical symptoms, blood tests, and examination.
At Advicon Imaging, DECT gout imaging is performed using modern CT technology tailored to minimise radiation while providing precise visualisation of crystal deposits. Medicare‑eligible scans are fully bulk‑billed.
A DECT scan uses two different CT energy levels to identify uric acid crystals in joints affected by gout.
Your doctor may want to confirm gout, assess crystal deposits, or evaluate persistent joint pain when other tests are inconclusive.
No special preparation is required.
You will lie on the CT table while images are taken of the affected joints. No injections or contrast are usually needed. The scan is quick and painless.
No. DECT is completely non‑invasive and painless.
Yes, but the dose is low and carefully controlled. DECT offers significant diagnostic value that outweighs the small radiation exposure.
DECT is highly accurate, especially in chronic gout, with sensitivity and specificity commonly above 80–90%. However, early flare‑ups or significant osteoarthritis may reduce accuracy.
It can detect even small collections of MSU crystals, but false positives or negatives may occur in specific conditions.
Yes. You can resume all normal activities immediately.
Reports are usually sent to your doctor within 24–48 hours.
Yes. DECT gout scans are fully bulk‑billed for Medicare‑eligible patients at Advicon Imaging.